<code id='4A3095C16E'></code><style id='4A3095C16E'></style>
      • <acronym id='4A3095C16E'></acronym>
      <center id='4A3095C16E'><center id='4A3095C16E'><tfoot id='4A3095C16E'></tfoot></center><abbr id='4A3095C16E'><dir id='4A3095C16E'><tfoot id='4A3095C16E'></tfoot><noframes id='4A3095C16E'>
      • <optgroup id='4A3095C16E'><strike id='4A3095C16E'><sup id='4A3095C16E'></sup></strike><code id='4A3095C16E'></code></optgroup>
        5. <b id='4A3095C16E'><label id='4A3095C16E'><select id='4A3095C16E'><dt id='4A3095C16E'><span id='4A3095C16E'></span></dt></select></label></b><u id='4A3095C16E'></u>
          <i id='4A3095C16E'><strike id='4A3095C16E'><tt id='4A3095C16E'><pre id='4A3095C16E'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / explore / focus      
           
     
           
      
          focus 
           
      
           
      
           
       2025-09-30 17:39:50 
   
      
           
      
           
                        
          focus  
          
                                   
                 
                                      author：hotspot   
                                        
                                      
                                      Page View：6
                                  
                                    
          
                                   
          Editor’s note: A recording of the event is embedded below.
          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.
          advertisement
          Featured Speakers
          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Study finds gene variants tied to breast cancer risk in Black women
                                
                            
          Next article：  
                                      
                                          Walensky prepares to leave CDC — and Congress — behind
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles